Choroideremia Research Foundation - Cure CHM

Research ServicesMassachusetts, United States11-50 Employees

The Choroideremia Research Foundation - Cure CHM is an international nonprofit focused on choroideremia, a hereditary retinal degenerative disease. It raises funds to support scientific research toward a treatment or cure and provides education and resources for those affected, as well as public information about the condition. Based in Springfield, Massachusetts, the organization sits within the research services sector and coordinates activities intended to advance understanding and awareness of choroideremia.

Its primary audience includes individuals affected by choroideremia and the wider community seeking information about the disease. In 2025, CRF expanded its scope by acquiring Spark Therapeutics' SPK-7001 gene therapy assets for CHM after the program was discontinued, reflecting ongoing efforts to pursue treatment options.

Sign up for free to view info

Email Format Employee directory